Scientists challenge the efficacy of folfiri in a colorectal cancer subtype
The current classification system for colorectal cancer, which is based on genetic expression profiles, cannot be used to predict drug responses to FOLFIRI. This is the conclusion reached by a team from the Spanish National ...
Nov 7, 2014
0
0